DNases, Ligases, and RNA Polymerases Market Research 2024-2034: Burgeoning Opportunities in Emerging Applications, Collaborative Partnerships, and Adoption of Enzyme-based Diagnostics
Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "Dnases, Ligases, and RNA Polymerases Market by Dnases Application, by Ligases Application, by RNA Polymerases Application, by End-user, and by Region" report has been added to ResearchAndMarkets.com's offering.The global DNases, ligases, and RNA polymerases market accounted for USD 0.804 billion in 2023 and is expected to reach USD 2.45 billion by 2034 with a CAGR of 10.66% during the forecast period 2024-2034. The market will grow due to factors such as growing emphasis on life sciences research, advancements in RNA-based therapeutics, rising demand for biopharmaceutical products, and support from institutions and the government.
The market for ligases, RNA polymerases, and DNases worldwide is driven by several reasons. These enzymes are needed for the growing biopharmaceutical industry to produce biocatalysts, purify DNA, and possibly even use gene therapy. RNA polymerases are necessary to manufacture mRNA vaccines and RNAi therapeutics, opening up a new market for growth.
For instance, Almac Group said in March 2024 that the two newly constructed facilities at its headquarters in Craigavon, Northern Ireland, were complete. The peptide API synthesis as well as the commercial manufacturing and packing of sachet pharma product presentations are anticipated to increase with the opening of these new facilities.
North American region is anticipated to have the highest revenue share during the forecast period owing to advanced healthcare infrastructure, significant investments in research and development, and a high adoption rate of molecular biology technologies.
Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly expanding biotechnology and pharmaceutical industries, increasing government initiatives to support scientific research, and rising investment in healthcare infrastructure. For instance, the NEBNext UltraExpress DNA and RNA library preparation kits for next-generation sequencing were introduced by New England Biolabs in November 2023.By DNases application, the biopharmaceutical processing segment accounted for the highest revenue-grossing segment in the global DNases, ligases, and RNA polymerases market in 2023 owing to the increasing demand for biopharmaceuticals, extensive use in removing DNA contaminants, and significant investments in research and development.
For instance, in January 2024, the company's selectAZyme enzyme screening collection was expanded with the introduction of an RNA Ligase (RNAL) enzyme kit by Almac Science, a part of Almac Group. Additionally, the other applications segment is predicted to grow at the fastest CAGR during the forecast period owing to the expanding use of these enzymes in emerging fields such as synthetic biology, personalized medicine, and advanced molecular diagnostics.By ligases application, the other applications segment accounted for the highest revenue-grossing segment in the global DNases, ligases, and RNA polymerases market in 2023 owing to the increasing utilization in diverse fields such as gene therapy, molecular diagnostics, and synthetic biology, as well as significant advancements in biotechnological research.
For instance, in March 2023, the University of Manchester, AstraZeneca, Novartis, and the Centre for Process Innovation Limited joined together to transform oligonucleotide synthesis. Additionally, the oligonucleotide synthesis segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for custom oligonucleotides in genetic research, advancements in gene editing technologies like CRISPR, and increasing applications in diagnostics and therapeuticsBy RNA polymerases application, the mRNA production segment accounted for the highest revenue-grossing segment in the global DNases, ligases, and RNA polymerases market in 2023 owing to the surge in demand for mRNA vaccines, especially COVID-19 vaccines, and the increasing development of mRNA-based therapeutics for various diseases.
For instance, in January 2024, Almac Science, a division of the Almac Group, added an RNA Ligase (RNAL) enzyme kit to the company's selectAZyme enzyme screening library. Additionally, the others segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing application of these enzymes in innovative fields such as synthetic biology, personalized medicine, and advanced molecular diagnostics, as well as ongoing technological advancements and expanding research initiatives.By end-user, the research and academic institutions segment accounted for the highest revenue-grossing segment in the global DNases, ligases, and RNA polymerases market in 2023 owing to the significant demand for advanced molecular biology tools and techniques for various research projects and academic studies. For instance, Illumina and Deerfield Management worked together in May 2022.
The companies collaborated to select projects that had a higher chance of success utilizing genetic methods and intrinsic knowledge in order to reduce the expense of research and development and encourage the approval of innovative treatments. Additionally, the diagnostic laboratories segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing prevalence of infectious diseases and the rising demand for accurate molecular diagnostics for early disease detection and management.
Key Attributes:
Report Attribute
Details
No. of Pages
200
Forecast Period
2023 - 2034
Estimated Market Value (USD) in 2023
$0.8 Billion
Forecasted Market Value (USD) by 2034
$2.45 Billion
Compound Annual Growth Rate
10.6%
Regions Covered
Global
Market Dynamics
Drivers Analysis
Increasing research activities
Advancements in biotechnology
Rising demand for personalized medicine
Expansion of the biopharmaceutical industry
Restraints Analysis
Regulatory hurdles
High cost
Technical challenges
Opportunities Analysis
Emerging applications
Collaborative partnerships
Adoption of enzyme-based diagnostics
Threats Analysis
Competition from alternative technologies
Intellectual property issues
Safety concerns
Trend Analysis
CRISPR-Cas technologies
Sustainability initiatives
Industrial biocatalysis
Competitor Analysis
Thermo Fisher Scientific Inc.
New England Biolabs
Merck KGaA
Promega Corporation
Agilent Technologies
QIAGEN
Takara Bio Inc.
Illumina Inc.
Roche Holding AG
Bio-Rad Laboratories Inc.
Enzymatics Inc.
GenScript Biotech Corporation
Lonza Group Ltd.
OriGene Technologies Inc.
Becton
Dickinson and Company (BD)
DNases, Ligases, And RNA Polymerases Market Analysis & Forecast by DNases Application 2023 - 2034 (Revenue USD Bn)
Biopharmaceutical Processing
Other Applications
DNases, Ligases, And RNA Polymerases Market Analysis & Forecast by Ligases Application 2023 - 2034 (Revenue USD Bn)
Oligonucleotide Synthesis
Other Applications
DNases, Ligases, And RNA Polymerases Market Analysis & Forecast by RNA Polymerases Application 2023 - 2034 (Revenue USD Bn)
mRNA Production
Other Applications
DNases, Ligases, And RNA Polymerases Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
Biopharmaceutical Processing
Research and Academic Institutions
Diagnostic Laboratories
Pharmaceutical Companies
DNases, Ligases, And RNA Polymerases Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
North America
U.S.
Canada
Europe
Germany
France
UK
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Rest of LATAM
Middle East & Africa
South Africa
GCC
Rest of MEA
For more information about this report visit https://www.researchandmarkets.com/r/sv1pte
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
Global DNases, Ligases, And RNA Polymerases Market
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
an hour ago
- Business Upturn
TOP RANKED ROSEN LAW FIRM Encourages Vera Bradley, Inc. Investors to Inquire About Securities Class Action Investigation
NEW YORK, July 27, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Vera Bradley, Inc. (NASDAQ: VRA) resulting from allegations that Vera Bradley may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Vera Bradley securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. WHAT TO DO NEXT: To join the prospective class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. WHAT IS THIS ABOUT: On June 11, 2025, Vera Bradley announced its financial results for the first quarter of the 2026 fiscal year. Commenting on the results, Vera Bradley's CEO stated that '[o]ur first quarter results were disappointing as top line and profitability trends from the previous several quarters continued.' On this news, Vera Bradley's stock fell 19% on June 11, 2025. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. ——————————- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected]
Business Upturn
an hour ago
- Business Upturn
Presentation Uncovers Forgotten U.S. Policy Unlocking America's Most Strategic Hidden Resource
By GlobeNewswire Published on July 27, 2025, 17:00 IST Washington, D.C., July 27, 2025 (GLOBE NEWSWIRE) — A Hidden Framework Built for Crisis In a recently released presentation , former White House advisor and CIA consultant Jim Rickards has drawn attention to a largely forgotten section of U.S. law that could help America reclaim control over some of the world's most strategic resources. 'This story is not about real estate… the government retained the most valuable part' , Rickards says in The American Birthright . According to Rickards, that 'valuable part' may now be poised to play a defining role in America's national defense and technological future. What the World Needs to Build the Future Rickards highlights how buried minerals fuel the devices and infrastructure that define the 21st century: AI Chips & Semiconductors – Powered by silicon, gallium, and copper. Electric Vehicles – Depend on lithium, cobalt, nickel, and manganese. Missiles & Satellites – Require neodymium, dysprosium, and rare earths. 'These seemingly obscure minerals… they're the building blocks of everything from NVIDIA chips to advanced military weapons,' Rickards explains. Unlocking the Subsurface Arsenal At the center of Rickards' presentation is Title 30 of U.S. law — a little-known statute that gives citizens the right to stake claims on public lands, many of which turned out to be rich in minerals. Rickards notes: 'Back then, anyone could make a claim… pay $2 to $5 per acre… and do a minimal amount of work'. But today, the stakes are higher. With foreign powers tightening their grip on rare earth exports, the U.S. may need to tap its own mineral base—this time for chips, batteries, defense, and AI dominance. Defense Signals Are Flashing Rickards points to a surge in U.S. government activity: The Pentagon is investing directly in domestic mineral extraction firms under emergency wartime powers. Global competitors are hoarding or restricting exports of gallium, germanium, and other critical metals New AI tools are accelerating mineral discovery across the continental U.S. Rickards warns: 'We have truly massive mineral wealth here… It's not hard to extract. We know where it is. And how to get it'. Access the Presentation: The American Birthright Rickards' presentation explores how global tensions and a shifting tech landscape are converging beneath the surface—literally. For now, the presentation is available for public viewing , offering an inside look at how this story may quietly reshape America's next chapter. About Jim Rickards Jim Rickards is a former advisor to the CIA, Pentagon, White House, and Treasury. With a background in economics, law, and intelligence, he's helped guide U.S. leaders through major geopolitical shifts. Today, Rickards serves as the editor of Strategic Intelligence , where he provides monthly briefings on national security, economics, and resource strategy. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Business Upturn
an hour ago
- Business Upturn
BTC Price Hits $118,000: HashJ Launches First Short-Term Contracts for Scalable Rewards
Zurich, Switzerland, July 27, 2025 (GLOBE NEWSWIRE) — MGPD Finance Limited, doing business as HashJ, today announced the official launch of its short-term BTC contract offerings, designed to help everyday users benefit from Bitcoin's record-breaking rally past $118,000. The launch marks a new chapter in making digital asset participation simpler, faster, and more predictable—especially for mobile-first users worldwide. HashJ's platform now enables fixed-term Bitcoin reward plans ranging from 3 to 30 days, with flexible entry amounts and automated settlement. These BTC-linked contracts are designed for users who prefer predictable returns without engaging in high-risk trading or managing complex wallets. Understanding Bitcoin-Linked Contracts Unlike traditional blockchain products that require deep technical knowledge, HashJ's short-term contracts are built for accessibility. Leveraging protocol upgrades like Taproot and Script enhancements, Bitcoin now supports basic automated actions that allow users to receive rewards based on time or market performance. Instead of trading, users can activate a short-term BTC contract and receive returns once predefined terms are met. These plans are often referred to as: BTC reward contracts Bitcoin income plans Automated BTC participation tools How It Works Each plan allows users to commit a set amount of BTC (or equivalent), which is automatically tracked through the duration of the contract. At the end of the term—such as 7 or 14 days—the user receives both the original amount and a BTC-denominated reward, without manual claiming or market monitoring. The system is entirely self-directed and designed for ease of use, particularly through the HashJ app and online platform. Why This Launch Matters in 2025 Bitcoin Price Surge With BTC price exceeding $118,000, many users are looking for safe and structured ways to grow holdings. HashJ's short-term plans offer a non-speculative alternative to trading. Simplified Access via HashJ New users can register at and receive a $118 welcome package—including a $100 trial contract and $18 in real value—to begin participating immediately. Predictable Returns in Unpredictable Times Fixed-term plans ranging from 3 to 30 days allow users to avoid timing the market. Contract terms are transparent, short, and aligned with Bitcoin performance trends. HashJ Product Snapshot Platform : Mobile + Web-based : Mobile + Web-based Live Users : 2M+ registered worldwide : 2M+ registered worldwide Welcome Offer : $118 bonus for new users : $118 bonus for new users Contract Terms : 3–30 days : 3–30 days Security : Encrypted wallet access, immutable transaction records, and real-time performance tracking : Encrypted wallet access, immutable transaction records, and real-time performance tracking Support: 24/7 multilingual assistance 'This launch reflects our mission to help users earn BTC without needing to be traders or technicians,' said a spokesperson for HashJ. 'With short-term contracts, anyone can now engage with Bitcoin in a safe, flexible, and rewarding way.' In addition to the welcome bonus, HashJ also runs a VIP program offering tiered benefits for high-volume participants, as well as an affiliate program that rewards users for referring others through unique invite codes. These features are designed to foster long-term engagement and community-led growth. Real-World Example A new user funds a $50 BTC contract for 7 days through the HashJ platform. After the term expires, the user receives the original amount plus a predetermined reward—automatically and securely—without engaging in trading or price speculation. Built for Security HashJ's contract infrastructure is built on robust blockchain standards, including: Transparent reward logic Multi-signature wallet protection Encrypted user access keys Contract time-locks and early exit flexibility All BTC reward contracts operate within a decentralized, permissionless framework that prioritizes security and ease of use. Looking Ahead: The Future of BTC Participation With Bitcoin playing a growing role in decentralized finance, HashJ's short-term contracts position the company at the forefront of non-trading-based BTC growth models. Future plans include: Integration with cross-chain BTC products Trigger-based contracts linked to BTC market events Smart wallet compatibility BTC-linked token and NFT access About MGPD Finance Limited (HashJ) MGPD Finance Limited, doing business as HashJ, is a fintech company based in the United Kingdom. Founded in 2018, the company provides contract-based digital reward systems for BTC, ETH, DOGE, and XRP, with over 2 million users across more than 90 countries. For more information, visit: Download: Available on iOS and Android Business Inquiries: [email protected]
